Treatment of advanced neuroblastoma with i-131 meta-iodobenzylguanidine
- 15 February 1991
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Radiobiological rationale for hyperfractionation in the radiotherapy of neuroblastomaInternational Journal of Radiation Oncology*Biology*Physics, 1987
- 131-metaiodobenzylguanedine therapy of neuroblastoma in childhoodEuropean Journal of Pediatrics, 1987
- Radionuclide therapy of neural crest tumorsMedical and Pediatric Oncology, 1987
- Therapeutic use of 131I‐metaiodobenzylguanidine (MIBG) in neuroblastoma: A phase II study in nine patientsMedical and Pediatric Oncology, 1987
- Treatment of neuroblastoma with metaiodobenzylguanidine: Results and side effectsMedical and Pediatric Oncology, 1987
- The radiobiology of human neuroblastomaRadiotherapy and Oncology, 1985
- IMAGING OF MEDULLARY THYROID CANCER WITH 131I-MIBGThe Lancet, 1984
- New approach to the localisation of phaeochromocytoma: imaging with iodine-131-meta-iodobenzylguanidine.BMJ, 1984
- Cyclic, low-dose total body irradiation for metastatic neuroblastomaInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: A pilot studyInternational Journal of Radiation Oncology*Biology*Physics, 1981